Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Colorectal Neoplasms × Sorafenib × Clear all

Phase

Status

Completed 8 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 29 Carcinoma, Renal Cell 15 Liver Neoplasms 11 Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Leukemia, Myeloid, Acute 5 Kidney Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Thyroid Neoplasms 3 Prostatic Neoplasms 3 Lung Neoplasms 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma 3 Urinary Bladder Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Breast Neoplasms, Male 2 Blast Crisis 2 Adenocarcinoma, Follicular 2 Urethral Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Diseases 1

Interventions

Irinotecan 49 Bevacizumab 47 Oxaliplatin 43 Leucovorin 42 Fluorouracil 42 Capecitabine 40 Cetuximab 38 pembrolizumab 18 IFL protocol 12 regorafenib 8 Nivolumab 8 Panitumumab 7 Cyclophosphamide 6 Colonoscopy 6 trifluridine tipiracil drug combination 5 atezolizumab 5 Radiotherapy 5 Metformin 5 Immunohistochemistry 5 Celecoxib 5 spartalizumab 4 Trastuzumab 4 Surgical Procedures, Operative 4 Mitomycin 4 Interleukin-2 4 Gene Expression Profiling 4 Gemcitabine 4 Folfox protocol 4 Docetaxel 4 Chemotherapy, Adjuvant 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00889343 2013-03-04

FOSCO

AIO-Studien-gGmbH

Phase 2 Terminated

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡